The detection of significant hypoglycaemiamay be life saving. Hypoglycaemia may be spontaneous, drug-induced or iatrogenic, the latter occurring during pituitary function testing (insulin stress test) or during glucose uptake studies (insulin sensitivity test). In these settings, the patient is given a standard dose of insulin intravenously (0'1 U/kg of soluble insulin) and the resulting fall in plasma glucose is measured. During the insulin stress test blood glucose is measured to confirm, retrospectively, that hypoglycaemia has been achieved. On rare occasions insulin stress testing has resulted in deaths. I In contrast, the insulin sensitivity test examines the rate of fall of glucose over 15-20 min in response to a bolus of insulin." In this setting, significant hypoglycaemia needs to be avoided as the ensuing sympathetic response may produce profound and unpleasant symptoms for the patient together with release of hormones antagonizing the actions of insulin rendering the study unreliable.' The measurement of whole blood glucose by the HemoCue analyser takes approximately 60 s from the time of sampling giving an on the spot measure of glucose concentration. In the context of insulin sensitivity testing we have compared the reliability of whole blood glucose measurements by HemoCue analyser with plasma glucose measured by a laboratory glucose analyser.
Venous blood samples were drawn from five healthy volunteers on 11 different study days through an unheparinized angiocath sited in the ante-cubital fossa. One hundred and thirtythree samples were drawn in total at various intervals during a 25 min study in which plasma Correspondence: Dr R P Young glucose concentrations fell from fasting levels (4'5-6'5 mmol/L), to trough levels (2,0-4,0 mmol/L) and then rose again following intravenous and lor oral glucose administration. Based on our previous experience, we elected to reverse the fall in glucose concentration when HemoCue measurements approached 3· 0 mmol/L. Following blood collection, whole blood glucose was immediately measured by HemoCue analyser (B Glucose Photometer HemoCue AB, Angelholm, Sweden). We found the coefficients of variation (CV) for the HemoCue for 15 measurements were 2'5%, 2'7lr1o and 4·0lrlo at means (SD) of 5·1 mmol/L (0'1),3'4 mmol/L (0'1) and 2·2 mmol/L (0'1), respectively. The remaining blood sample was collected in 1.5 mL screw cap tubes (Microsample container, Sarstedt Ltd, Leicester, UK) containing sodium flouride. The flouridated samples were stored on ice until completion of the 25 min study at which time they were immediately centrifuged (within 10 min) and the plasma was aspirated off and stored for 3 h at 4°C. These measures were designed to minimize disparity due to glycolysisinduced reduction in glucose concentrations. Figure I shows the absolute difference between these two methods (YSI plasma glucose (reference method) minus the HemoCue whole-blood glucose) plotted against their mean. Figure 2 compares the fall in YSI and HemoCue glucose concentrations in four representative subjects. No subjects reported symptoms during the hypoglycaemic periods in all 11 studies. Whole blood glucose concentrations are normally lower than plasma glucose in paired samples due to the dilutional effects of cellular constituents of whole blood and, if left unseparated, cellular glycolysis. However, in our study the HemoCue analyser consistently measured higher concentrations than those measured by the YSI glucose analyser. We believe this difference relates to a problem of accuracy in the HemoCue analyser rather than precision which we found to be less than 4·0070 at hypoglycaemic levels and comparable to other near-patient testing methods.! Wiener also found the HemoCue analyser to measure slightly higher whole blood concentrations compared to YSĨ
Mean glucose concentration lmmoll L 1 plasma concentrations and reported a CV of 2070 for the HemoCue analyser at hypoglycaemic levels." On crude inspection of our data the relationship between the glucose concentrations measured by these methods appears to be reasonably consistent across the range from normoglycaemic to hypoglycaemic levels. In contrast the Bland-Altman analysis (Fig. I) shows, for isolated points, the absolute concentration measured by HemoCue may be greater than 1. 0 mmol/L higher than YSI concentrations even when approaching hypoglycaemic levels. However, the rates of fall in glucose concentration measured by the two methods were found to be similar (Fig. 2) . In addition, plasma glucose concentrations did not fall below 2· 0 mmol/L and no hypoglycaemic symptoms were experienced by our patients using a HemoCue lower limit of 3· 0 mmol/L.
CONCLUSION
We conclude from our study that HemoCue measurements of glucose concentrations are not sufficiently accurate to replace laboratory methods for research purposes. However, HemoCue measurements are quick and sufficiently precise to follow falls in glucose concentrations during iatrogenic hypoglycaemia as long as the HemoCue analyser has been critically compared with more reliable methods. Using this approach we, like others, have found the HemoCue analyser to be very convenient and easy to use and would strongly recommend its use in insulin stress testing and insulin sensitivitytesting where life threatening hypoglycaemia can be readily avoided.
